; and (C) the performance enhancement goals that were not achieved during the previous fiscal year and a detailed description of efforts the agency has put in place for the current fiscal year to improve the ability of the agency to meet each such goal for the current fiscal year. (c) Enhanced communication (1) Communications with congress Each fiscal year, as applicable, representatives from the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research shall meet with representatives from the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives regarding the contents of the corrective action reports described in subsection (b) and the annual performance reports under subsection (a). (2) Participation in congressional hearing Each fiscal year, as applicable, representatives from the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research shall participate in a public hearing before the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, to report on the contents described in the reports under this section. Such hearing shall occur not later than 120 days after the end of each fiscal year for which fees are collected under this part. (3) Publicly available updates The Secretary shall provide an update on progress made for the corrective action report during the following fiscal year on the publicly available Internet website of the Food and Drug Administration every 30 business days. . 4. Prohibiting use of funds for facility maintenance (a) PDUFA Section 735(7)(C) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379g(7)(C) ) is amended by striking renovation, and repair of facilities and acquisition, maintenance, and repair of fixtures, furniture, scientific equipment, and other necessary materials and supplies and inserting and necessary scientific equipment . (b)